Anthem Biosciences Limited IPO
Anthem Biosciences Limited was a mainboard IPO in the Biotechnology sector, offered at ₹540–₹570 per share to raise ₹3,395 crore. The issue was subscribed 63.86× overall (QIBs 182.65×, NIIs 42.36×, retail 5.64×). It listed on 21 Jul 2025 at ₹723 and closed its first day at ₹730, a listing gain of +28.1% versus the ₹570 issue price. It now trades around ₹829 (+45.4% versus the issue price).
Frequently asked questions
- How many times was the Anthem Biosciences Limited IPO subscribed?
- The Anthem Biosciences Limited IPO was subscribed 63.86× overall — 182.65× in the QIB category, 42.36× among non-institutional investors, 5.64× in retail.
- What were the Anthem Biosciences Limited IPO listing gains?
- Anthem Biosciences Limited listed on 21 Jul 2025 at ₹723, closing its first day at ₹730 — a listing gain of +28.1% versus the ₹570 issue price.
- What were the retail allotment odds for the Anthem Biosciences Limited IPO?
- Retail was subscribed 5.64×, so a single-lot application had roughly a 17.7% chance of allotment (about 1 in 6), and allotment was finalised on 17 Jul 2025.
- What was the price band and lot size of the Anthem Biosciences Limited IPO?
- The price band was ₹540–₹570 per share, with a minimum lot of 26 shares (₹14,820 at the upper band).
- Who were the registrar and lead manager for the Anthem Biosciences Limited IPO?
- KFin Technologies Limited was the registrar, and JM Financial was the book-running lead manager.